Near the end of the discussion Rohit Sood and Don were asked about capitalization and what I got from Don, if I understood him correctly, was that RVX will continue with private placements (small thinking in my mind) and hold off on BoM2 until the Covid situation settles and they can get that trial moving (seems to make sense).

So we coninue with death by 1000 small cuts.

Then Don discussed the Covid trial and essentially said it could be the game changer for the future economics of RVX (my interpretation). Don also said the Covid trial will start in a few days (hope I heard that right)...Wed, Thurs, Fri??? So the dice is ready to roll.

RVX has the science and publications to prove their science.

Lets roll the dice and hope.

Rohit Sood seems like a pretty sharp guy so if the Covid trial succeeds, whenever that may be, I'm feeling somewhat reassured that a launch could be effective. I sense that the Eversana agreement brings some much needed leadership to RVX. They seem organized, thoughtful, experienced enough and with a strong network to get the job done.

I'll reserve other comments for obvious reasons   :) .

GLTA

Toinv